Company Profiles

driven by the PitchBook Platform

Altor BioScience

Description

Developer of immunotherapies designed to treat cancer and viral infections. The company's engineered cytokine technology platforms focus on the immunostimulatory properties of the cytokines IL-15 and IL-2, as well as offer links between the innate and adaptive arms of the immune system and induce the activation, proliferation and persistence of NK and T cells, which are critical in the body's defense against cancer and infection, enabling HIV infected individuals and patients with hematological tumors to regulate the function of the immune system.

2002

Founded

M&A

Status

51-200

Employees

M&A

Latest Deal Type

$1.08B

Latest Deal Amount

$104M

Total Amount Raised

Description

Developer of immunotherapies designed to treat cancer and viral infections. The company's engineered cytokine technology platforms focus on the immunostimulatory properties of the cytokines IL-15 and IL-2, as well as offer links between the innate and adaptive arms of the immune system and induce the activation, proliferation and persistence of NK and T cells, which are critical in the body's defense against cancer and infection, enabling HIV infected individuals and patients with hematological tumors to regulate the function of the immune system.

Website:

www.altorbioscience.com

Ownership Status

Acquired/Merged (Operating Subsidiary)

Financing Status

Formerly VC-Backed

Primary Industry

Biotechnology

Other Industries

Other Pharmaceuticals and Biotechnology
Drug Discovery

Primary Office

2810 North Commerce Parkway Miramar, FL 33025United States +1 (954) 443-8600
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Altor BioScience's full profile, request a free trial.

Altor BioScience Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Altor BioScience Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Altor BioScience Executive Team (7)

NameTitleBoard
Seat
Contact
Info
Hing Wong Ph.DFounder, President, Chief Executive Officer & Board Member
Rick GreeneChief Financial Officer
Jeffrey Weber Ph.DConsulting Medical Director
Peter Rhode Ph.DSenior Vice President, Research & Development
Amy Rock Ph.DVice President, Clinical Development & Regulatory Affairs
Hing Wong Ph.D Founder, President, Chief Executive Officer & Board Member
Rick Greene Chief Financial Officer
Jeffrey Weber Ph.D Consulting Medical Director
Peter Rhode Ph.D Senior Vice President, Research & Development
Amy Rock Ph.D Vice President, Clinical Development & Regulatory Affairs

Altor BioScience Board Members (2)

NameRepresentingRoleSinceContact
Info
Adam Waldman JDSelfBoard Member000 0000
Hing Wong Ph.DAltor BioScienceFounder, President, Chief Executive Officer & Board Member000 0000
Adam Waldman JD Board Member Self
Hing Wong Ph.D Founder, President, Chief Executive Officer & Board Member Altor BioScience
Request full access to PitchBook